JP2022511776A5 - - Google Patents
Info
- Publication number
- JP2022511776A5 JP2022511776A5 JP2021530078A JP2021530078A JP2022511776A5 JP 2022511776 A5 JP2022511776 A5 JP 2022511776A5 JP 2021530078 A JP2021530078 A JP 2021530078A JP 2021530078 A JP2021530078 A JP 2021530078A JP 2022511776 A5 JP2022511776 A5 JP 2022511776A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024213225A JP7808674B2 (ja) | 2018-11-30 | 2024-12-06 | Ａａｖウイルスベクター及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773894P | 2018-11-30 | 2018-11-30 | |
| US62/773,894 | 2018-11-30 | ||
| US201962835242P | 2019-04-17 | 2019-04-17 | |
| US62/835,242 | 2019-04-17 | ||
| PCT/US2019/063649 WO2020113034A1 (en) | 2018-11-30 | 2019-11-27 | Aav viral vectors and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213225A Division JP7808674B2 (ja) | 2018-11-30 | 2024-12-06 | Ａａｖウイルスベクター及びその使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022511776A JP2022511776A (ja) | 2022-02-01 |
| JPWO2020113034A5 JPWO2020113034A5 (https=) | 2022-12-01 |
| JP2022511776A5 true JP2022511776A5 (https=) | 2022-12-01 |
| JP7677887B2 JP7677887B2 (ja) | 2025-05-15 |
Family
ID=69167903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530078A Active JP7677887B2 (ja) | 2018-11-30 | 2019-11-27 | Ａａｖウイルスベクター及びその使用 |
| JP2024213225A Active JP7808674B2 (ja) | 2018-11-30 | 2024-12-06 | Ａａｖウイルスベクター及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213225A Active JP7808674B2 (ja) | 2018-11-30 | 2024-12-06 | Ａａｖウイルスベクター及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220001028A1 (https=) |
| EP (1) | EP3886919A1 (https=) |
| JP (2) | JP7677887B2 (https=) |
| KR (1) | KR20210099025A (https=) |
| CN (2) | CN120860258A (https=) |
| AU (1) | AU2019389047A1 (https=) |
| BR (1) | BR112021009739A2 (https=) |
| CA (1) | CA3116630A1 (https=) |
| IL (1) | IL282885A (https=) |
| MX (1) | MX2021006359A (https=) |
| TW (2) | TWI897418B (https=) |
| WO (1) | WO2020113034A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3837374A4 (en) * | 2018-08-15 | 2022-06-08 | Biogen MA Inc. | COMBINATION THERAPY FOR SPINAL MUSCLE ATROPHY |
| TW202140791A (zh) * | 2020-01-13 | 2021-11-01 | 美商霍蒙拉奇醫藥公司 | 治療苯酮尿症之方法 |
| CN112121179A (zh) * | 2020-09-15 | 2020-12-25 | 山东兴瑞生物科技有限公司 | 一种组合物及其在治疗脊髓性肌萎缩症中的应用 |
| US20240084323A1 (en) * | 2021-01-13 | 2024-03-14 | Dignity Health | Modulation of chitinase protein expression |
| EP4377459A2 (en) | 2021-07-30 | 2024-06-05 | Tune Therapeutics, Inc. | Compositions and methods for modulating expression of frataxin (fxn) |
| WO2023010135A1 (en) | 2021-07-30 | 2023-02-02 | Tune Therapeutics, Inc. | Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2) |
| EP4380602A4 (en) * | 2021-08-03 | 2025-06-11 | The Regents Of The University Of California | ADENO-ASSOCIATED VIRAL (AAV)-MEDIATED EXPRESSION OF SPHINGOSINE 1-PHOSPHATE LYASE (SPL) FOR THE TREATMENT OF PULMONARY FIBROSIS |
| CN114276419B (zh) * | 2021-12-30 | 2023-11-17 | 上海勉亦生物科技有限公司 | 肌肉高亲和性的新型腺相关病毒衣壳蛋白及其应用 |
| KR20230152503A (ko) * | 2022-04-27 | 2023-11-03 | 주식회사 헬릭스미스 | 척수강 내 투여에 최적화 된 간세포 성장인자 유전자가 도입된 aav 벡터 |
| KR102717399B1 (ko) * | 2022-05-10 | 2024-10-16 | 서울대학교산학협력단 | 인간 smn1 단백질 변이체 및 이의 용도 |
| WO2023246734A1 (en) | 2022-06-21 | 2023-12-28 | Skyline Therapeutics (Shanghai) Co., Ltd. | Recombinant aav for the gene therapy of sma disease |
| CA3261865A1 (en) | 2022-07-12 | 2024-01-18 | Tune Therapeutics, Inc. | TARGETED TRANSCRIPTIONAL ACTIVATION COMPOSITIONS, SYSTEMS AND METHODS |
| WO2024163683A2 (en) | 2023-02-01 | 2024-08-08 | Tune Therapeutics, Inc. | Systems, compositions, and methods for modulating expression of methyl-cpg binding protein 2 (mecp2) and x-inactive specific transcript (xist) |
| WO2024163678A2 (en) | 2023-02-01 | 2024-08-08 | Tune Therapeutics, Inc. | Fusion proteins and systems for targeted activation of frataxin (fxn) and related methods |
| WO2024238958A1 (en) * | 2023-05-18 | 2024-11-21 | Ultragenyx Pharmaceutical Inc. | Formulations comprising recombinant aav and methods of administering the same |
| WO2026028089A1 (en) | 2024-07-29 | 2026-02-05 | Novartis Ag | Compositions and methods for the treatment of lysosomal acid lipase deficiency (lal-d) |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| PT733103E (pt) | 1993-11-09 | 2004-07-30 | Targeted Genetics Corp | Criacao de elevados titulos de vectores de aav recombinantes |
| PT728214E (pt) | 1993-11-09 | 2004-11-30 | Ohio Med College | Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| AU707866B2 (en) | 1994-12-06 | 1999-07-22 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant AAV vectors |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| AU722196B2 (en) | 1995-08-30 | 2000-07-27 | Genzyme Corporation | Chromatographic purification of adenovirus and AAV |
| EP1983057A3 (en) | 1995-09-08 | 2009-01-07 | Genzyme Corporation | Improved AAV vectors for gene therapy |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| JP2001514845A (ja) | 1997-09-05 | 2001-09-18 | ターゲティッド ジェネティクス コーポレイション | 組換えａａｖベクターの高力価ヘルパーなし調製物を生成するための方法 |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| CA2406743A1 (en) | 2000-04-28 | 2001-11-08 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids |
| AU2002359284A1 (en) | 2001-12-17 | 2003-06-30 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US9233131B2 (en) | 2003-06-30 | 2016-01-12 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| CN1856576B (zh) * | 2003-09-30 | 2011-05-04 | 宾夕法尼亚州立大学托管会 | 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用 |
| SI2548560T1 (sl) | 2005-06-23 | 2015-12-31 | Isis Pharmaceuticals, Inc. | Sestavki in postopki za moduliranje izrezovanja smn2 |
| PT3305302T (pt) | 2009-06-17 | 2018-12-14 | Biogen Ma Inc | Composições e métodos de modulação de excisões de smn2 em um sujeito |
| DK2529020T3 (en) * | 2010-01-28 | 2018-08-06 | Childrens Hospital Philadelphia | SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| AU2013296425B2 (en) * | 2012-08-01 | 2018-06-07 | Nationwide Children's Hospital | Intrathecal delivery of recombinant adeno-associated virus 9 |
| MX380973B (es) * | 2013-05-01 | 2025-03-12 | Genzyme Corp | Composiciones y metodos para tratar la atrofia muscular espinal. |
| CN105377039A (zh) * | 2013-05-15 | 2016-03-02 | 明尼苏达大学董事会 | 腺相关病毒介导的基因向中枢神经系统转移 |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| AU2014340149B2 (en) * | 2013-10-22 | 2020-12-24 | Shire Human Genetic Therapies, Inc. | CNS delivery of mRNA and uses thereof |
| EP4410805A3 (en) * | 2014-03-18 | 2024-11-27 | University of Massachusetts | Raav-based compositions and methods for treating amyotrophic lateral sclerosis |
| JP6202701B2 (ja) | 2014-03-21 | 2017-09-27 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及びプログラム |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
| MA50016A (fr) * | 2017-07-06 | 2020-07-08 | Univ Pennsylvania | Thérapie génique médiée par aav9 pour traiter la mucopolysaccharidose de type i |
| MX2020004830A (es) * | 2017-11-08 | 2020-11-11 | Avexis Inc | Medios y metodo para preparar vectores virales y usos de los mismos. |
-
2019
- 2019-11-27 WO PCT/US2019/063649 patent/WO2020113034A1/en not_active Ceased
- 2019-11-27 BR BR112021009739-2A patent/BR112021009739A2/pt unknown
- 2019-11-27 MX MX2021006359A patent/MX2021006359A/es unknown
- 2019-11-27 AU AU2019389047A patent/AU2019389047A1/en active Pending
- 2019-11-27 CN CN202511011473.6A patent/CN120860258A/zh active Pending
- 2019-11-27 US US17/309,403 patent/US20220001028A1/en active Pending
- 2019-11-27 CA CA3116630A patent/CA3116630A1/en active Pending
- 2019-11-27 TW TW113118096A patent/TWI897418B/zh active
- 2019-11-27 CN CN201980078349.8A patent/CN113226380A/zh active Pending
- 2019-11-27 JP JP2021530078A patent/JP7677887B2/ja active Active
- 2019-11-27 EP EP19836872.2A patent/EP3886919A1/en active Pending
- 2019-11-27 KR KR1020217019147A patent/KR20210099025A/ko not_active Ceased
- 2019-11-27 TW TW108143173A patent/TWI844587B/zh active
-
2021
- 2021-05-03 IL IL282885A patent/IL282885A/en unknown
-
2024
- 2024-12-06 JP JP2024213225A patent/JP7808674B2/ja active Active